In severe OSA, OA did not affect circulating biomarker levels (NT-pro-BNP, CRP, IL-6, TNF-a, and its receptors, adiponectin, leptin, and P-selectin) and metabolic parameters compared with inactive OA. This evidence concerns the gene ADIPOQ and obstructive sleep apnea syndrome.